Big Biotechs Scare Off Short Sellers
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 49
Spain Faces a New Specter of Its 28,000 COVID-19 Deaths
Most large cities in Spain recently emerged from a months-long lockdown as the rise in the numbers of confirmed cases and COVID-19 deaths dropped sharply. But now, new cases have started to surge again.
Where Did Heart Disease and Cancer Go as COVID-19 Spread?
The focus of medical discussions in America has largely turned to the causes, symptoms, deaths, and cures for COVID-19. Lost to a signficant extent in the discussion about health is what remains the greatest…
AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Could US COVID-19 Deaths Top 2,000 a Day?
A growing number of scientists believe that the increase in daily deaths due to COVID-19 in America is not over.
Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that could be winners over a…
Owens & Minor Just Set Its Future Way Beyond COVID-19
There are no assurances that this stock will keep rising after such a rapid rise, but many investors with a long-term view now likely will view any pullbacks as opportunities to buy the stock.
BioNTech Raises Over $400 Million to Boost COVID-19 Efforts
BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than 160% year to date, it’s time to capitalize.
Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma
Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2 diabetes.
Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status
Moleculin Biotech joins the ever-expanding list of coronavirus stocks as the company announced that a second round of independent laboratory testing has confirmed the antiviral activity of WP1122.
Why Immuron’s New COVID-19 Study Is a Game Changer
Immuron continued its winning streak on Tuesday after the company announced that its IMM-124E has demonstrated neutralizing activity against the severe acute respiratory syndrome due to the virus that causes COVID-19.
Peru and Chile Take Brunt of COVID-19 Spread
While the United States considers its COVID-19 spread with horror, two much smaller nations have suffered tremendously as well.